Bank of the West’s Elevance Health ELV Stock Holding History

Bank of the West’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1.53M	Sell	2,980 -71	-2%	-$36K	0.18%	119
2022 Q3	$1.39M	Sell	3,051 -208	-6%	-$99.5K	0.18%	114
2022 Q2	$1.57M	Sell	3,259 -62	-2%	-$30.7K	0.2%	112
2022 Q1	$1.63M	Sell	3,321 -7,494	-69%	-$3.43M	0.17%	114
2021 Q4	$5.01M	Sell	10,815 -826	-7%	-$348K	0.47%	56
2021 Q3	$4.34M	Sell	11,641 -1,350	-10%	-$513K	0.45%	60
2021 Q2	$4.96M	Sell	12,991 -18,553	-59%	-$7.09M	0.51%	57
2021 Q1	$11.3M	Sell	31,544 -6,792	-18%	-$2.18M	1.27%	16
2020 Q4	$12.3M	Sell	38,336 -588	-2%	-$180K	1.44%	17
2020 Q3	$10.5M	Sell	38,924 -1,723	-4%	-$464K	1.4%	15
2020 Q2	$10.7M	Sell	40,647 -1,468	-3%	-$392K	1.44%	14
2020 Q1	$9.56M	Sell	42,115 -843	-2%	-$230K	1.49%	15
2019 Q4	$13M	Buy	42,958 +6,772	+19%	+$1.86M	1.52%	15
2019 Q3	$8.69M	Buy	36,186 +941	+3%	+$258K	1.05%	27
2019 Q2	$9.95M	Buy	35,245 +10,833	+44%	+$2.96M	1.17%	19
2019 Q1	$7.01M	Sell	24,412 -375	-2%	-$108K	0.82%	32
2018 Q4	$6.51M	Sell	24,787 -980	-4%	-$269K	0.78%	36
2018 Q3	$7.06M	Buy	25,767 +1,949	+8%	+$506K	0.83%	30
2018 Q2	$5.67M	Sell	23,818 -734	-3%	-$170K	0.7%	39
2018 Q1	$5.39M	Sell	24,552 -7,499	-23%	-$1.76M	0.68%	42
2017 Q4	$7.21M	Sell	32,051 -166	-0.5%	-$35.4K	0.9%	30
2017 Q3	$6.12M	Buy	32,217 +7,912	+33%	+$1.51M	0.77%	40
2017 Q2	$4.57M	Sell	24,305 -2,972	-11%	-$534K	0.59%	53
2017 Q1	$4.51M	Buy	27,277 +284	+1%	+$45.2K	0.57%	60
2016 Q4	$3.88M	Buy	26,993 +1,283	+5%	+$172K	0.54%	61
2016 Q3	$3.22M	Buy	25,710 +8,728	+51%	+$1.13M	0.44%	66
2016 Q2	$2.23M	Buy	+16,982	New	+$2.32M	0.32%	96

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Bank of the West's ELV Position: Q4 2022 in Review

Bank of the West reduced its Elevance Health (ELV) stake by 2.3% in Q4 2022, selling an estimated $36K and leaving 2,980 shares worth $1.53M. The position accounts for 0.18% of the portfolio, ranked #119.

Bank of the West first reported a position in ELV in Q2 2016 and has held it in 27 quarters since. The position peaked at $13M in Q4 2019. 1,549 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

Bank of the West held 2,980 shares of Elevance Health worth $1.53M as of Q4 2022.
Bank of the West sold 71 Elevance Health shares in Q4 2022, an estimated $36K.
Elevance Health made up 0.18% of Bank of the West's portfolio in Q4 2022, its #119 holding.
Bank of the West first reported a position in Elevance Health in Q2 2016 and has held it in 27 quarters since.
Bank of the West's Elevance Health position peaked at $13M in Q4 2019.
1,549 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Bank of the West's 13F filing for Q4 2022, filed 1 Feb 2023.